"My grandfather, whom I loved dearly, died of cancer when I was 15. I was highly motivated to do something that might lead to a cure." Read medicine laureate Gertrude Elion's story and how she used this difficult experience as research motivation: bit.ly/2WvsXJe pic.x.com/6vTRl6RiKK

身体の事を色々調べていたら、リサーチの対象になれそうなことを発見。 でも研究している場所が遠い: Harvard Cancer Center Washington University School of Medicine M D Anderson Cancer Center University of Washington Cancer Center (一番近い) 役に立てるならいいな。連絡してみます。

『Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial』 Nature Medicine 　16 Sep 2024 短期ICI併用が免疫活性化を引き起こすか? 化学療法なしネオアジュバント免疫療法は有効の可能性あり pic.x.com/cnmjtxumo1

ctDNA-based molecular residual disease and survival in resectable colorectal cancer Nature Medicine (2024) CIRCULATE-Japan GALAXY、リキッドバイオプシーによる大腸がんの再発リスクと術後治療効果の予測に有効性を確認―Nature Medicine誌で発表― ncc.go.jp/jp/information…

ようやくDL Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer | New England Journal of Medicine nejm.org/doi/full/10.10…

驚きのCR率68%！ 大腸癌の一部でオペはいらなくなる！？ Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial | Nature Medicine nature.com/articles/s4159…

ナイアガラ試験がNEJMに出ました。 Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer | New England Journal of Medicine nejm.org/doi/full/10.10…